SR ONE CAPITAL MANAGEMENT, LLC purchased 98.1% of their position (555.55K shares) of AVALYN PHARMA INC. on the open market
Open‑market purchase worth $10.00M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+1.42M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+489.49K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+277.78K
Price / share
$18.00
Trade value
$5M
% of position
Common Stock
Shares
+354.82K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+489.49K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+277.78K
Price / share
$18.00
Trade value
$5M
% of position
Net shares
+3.31M
Net value
$10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/1/2026 | C · Conversion | +1.42M | — | — | New position | 0.00 | 1.42M |
| Common Stock Indirect | 5/1/2026 | C · Conversion | +489.49K | — | — | 34.5% | 1.42M | 1.91M |
| Common Stock Indirect | 5/1/2026 | P · Purchase | +277.78K | $18.00 | $5M | 14.6% | 1.91M | 2.19M |
| Common Stock Indirect | 5/1/2026 | C · Conversion | +354.82K | — | — | New position | 0.00 | 354.82K |
| Common Stock Indirect | 5/1/2026 | C · Conversion | +489.49K | — | — | 138.0% | 354.82K | 844.31K |
| Common Stock Indirect | 5/1/2026 | P · Purchase | +277.78K | $18.00 | $5M | 32.9% | 844.31K | 1.12M |
| Total | +3.31M | $10M | ||||||
Series C-1 Convertible Preferred Stock
Common Stock
1.42M shares
Shares
−27.31M
Strike price
Held after
0.00
Exercisable
—
Series D Convertible Preferred Stock
Common Stock
489.49K shares
Shares
−9.42M
Strike price
Held after
0.00
Exercisable
—
Series C-1 Convertible Preferred Stock
Common Stock
354.82K shares
Shares
−6.83M
Strike price
Held after
0.00
Exercisable
—
Series D Convertible Preferred Stock
Common Stock
489.49K shares
Shares
−9.42M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C-1 Convertible Preferred Stock Indirect | Common Stock1.42M shares | 5/1/2026 | C · Conversion | −27.31M | — | 0.00 | |
| Series D Convertible Preferred Stock Indirect | Common Stock489.49K shares | 5/1/2026 | C · Conversion | −9.42M | — | 0.00 | |
| Series C-1 Convertible Preferred Stock Indirect | Common Stock354.82K shares | 5/1/2026 | C · Conversion | −6.83M | — | 0.00 | |
| Series D Convertible Preferred Stock Indirect | Common Stock489.49K shares | 5/1/2026 | C · Conversion | −9.42M | — | 0.00 |